The TLR4 agonist monophosphoryl lipid A drives broad resistance to infection via dynamic reprogramming of macrophage metabolism

Monophosphoryl lipid A (MPLA) is a clinically utilized toll-like receptor (TLR) 4 agonist that has been found to drive non-specific resistance to infection for up to two weeks. However, the molecular mechanisms conferring protection are not well understood. Here, we found that MPLA prompts resistanc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunol
Hlavní autoři: Fensterheim, Benjamin A., Young, Jamey D., Luan, Liming, Kleinbard, Ruby R., Stothers, Cody L., Patil, Naeem K., McAtee-Pereira, Allison G., Guo, Yin, Trenary, Irina, Hernandez, Antonio, Fults, Jessica B., Williams, David L., Sherwood, Edward R., Bohannon, Julia K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5964009/
https://ncbi.nlm.nih.gov/pubmed/29686054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1800085
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky